Measurements of blood pressure in 52064 men and women in the city of Bergen, Norway, who were 30 to 89 years in 1963, have been related to mortality occurring in different intervals of the follow-up period from 1963 throughout 1983. Blood pressure measurements obtained on one occasion were highly predictive of both coronary heart disease, stroke and all-cause mortality several years after measurements. The relative risk of stroke mortality associated with blood pressure varied little in the first ten to fifteen years, but the predictive power was clearly lower in the last five years of follow-up. The relative risk of death from coronary heart disease was stable in the whole period of follow-up. The risk curves relating coronary heart disease mortality to diastolic blood pressure in men and women aged 60–79 years at screening had the same shape in the first five years as in the rest of the follow-up. No J-shaped association was seen in either time interval.
1. Truett J, Cornfield J, Kannel WA multivariate analysis of the risk of coronary heart disease in Framingham. J Chron Dis1967; 20: 511–24.
2.
2. Kannel WB, Wolf PA, Verter Jet alEpidemiologic assessment of the role of blood pressure in stroke. JAMA1970; 214: 301–10.
3.
3. Kannel WB, Gordon T, Schwartz MJSystolic versus diastolic blood pressure and risk of coronary heart disease. Am J Cardiol1971; 27: 335–46.
4.
4. Holme I, Waaler HTFive-year mortality in the city of Bergen, Norway, according to age, sex and blood pressure. Acta Med Scand1976; 200: 229–39.
5.
5. Kannel WB, Dawber TR, Sorlie Pet alComponents of blood pressure and risk of atherothrombotic brain infarction: The Framingham Study. Stroke1976; 7: 327–31.
6.
6. Rabkin SW, Mathewson FAL, Tate RBPredicting risk of ischemic heart disease and cerebrovascular disease from systolic and diastolic blood pressures. Ann Int Med1978; 88: 342–5.
7.
7. Svärdsudd K, Tibblin GMortality and morbidity during 13.5 years' follow-up in relation to blood pressure. Acta Med Scand1979; 205: 483–92.
8.
8. Waaler HT. Specificity and sensitivity of blood pressure measurements. J Epidemiol Community Health1980; 34: 53–8.
10. Yano K, McGee D, Reed DMThe impact of elevated blood pressure upon 10-year mortality among japanese men in Hawaii: The Honolulu Heart Program. J Chron Dis1983; 36: 569–79.
11.
11. Lichtenstein MJ, Shipley MJ, Rose GSystolic and diastolic blood pressures as predictors of coronary heart disease mortality in the Whitehall Study. Br Med J1985; 291: 243–5.
12.
12. Martin MJ, Hulley SB, Browner WSet alSerum cholesterol, blood pressure, and mortality: Implications from a cohort of 361 662 men. Lancet1986; 2: 933–6.
13.
13. Tverdal ASystolic and diastolic blood pressures as predictors of coronary heart disease in middle aged Norwegian men. Br Med J1987; 294: 671–3.
14.
14. Rutan GH, Kuller LH, Neaton JDet alMortality associated with diastolic hypertension and isolated systolic hypertension among men screened for the multiple risk factor intervention trial. Circulation1988; 77: 504–14.
15.
15. Menotti A, Seccareccia F, Giampaoli Set alThe predictive role of systolic, diastolic and mean blood pressures on cardiovascular and all causes of death. J Hypertension1989; 7: 595–9.
16.
16. Stamler J, Neaton JD, Wentworth DNBlood pressure (systolic and diastolic) and risk of fatal coronary heart disease. Hypertension1989; 13, Suppl. 1: 1–2–12.
17.
17. Rutan GH, McDonald RH, Kuller LHA historical perspective of elevated systolic vs diastolic blood pressure from an epidemiological and clinical trial viewpoint. J Clin Epidemiol1989; 42: 663–73.
18.
18. MacMahon S, Peto R, Cufler Jet alBlood pressure, stroke, and coronary heart disease. Part I, Prolonged differences in blood pressure: Prospective observational studies corrected for the regression dilution bias. Lancet1990; 335: 765–74.
19.
19. Selmer RBlood pressure and twenty-year mortality in the city of Bergen, Norway. Am J Epidemiol1992; 136: 428–40.
20.
20. Westlund K, Nicolaysen RTen year mortality and morbidity related to serum cholesterol. Scand J Clin Lab Invest1972; 30, Suppl 127: 1–24.
21.
21. Samuelsson OG, Wilhelmsen LW, Pennert KM, Wedel H, Berglund GLThe J-shaped relationship between coronary heart disease and achieved blood pressure level in treated hypertension: Further analyses of 12 years of follow-up of treated hypertensives in the Primary Prevention Trial in Gothenburg, Sweden. J Hypertension1990; 8: 547–55.
22.
22. Famett L, Mulrow CD, Linn WD, Lucey CR, Tuley MRThe J-curve phenomen and the treatment of hypertension. Is there a point beyond which pressure reduction is dangerous? JAMA1991; 265: 489–95.
23.
23. Alderman MH, Ooi WL, Madhavan S, Cohen HTreatment-induced blood pressure reduction and the risk of myocardial infarction. JAMA1989; 262; 920–4.
24.
24. Thürmer HL, Lund-Larsen Per G, Tverdal A, Thelle DSTreatment of hypertension as a risk factor in a prospective study. Int J Risk Safety Med1990; 1, 267–78.
25.
25. Cruickshank JM, Thorp JM, Zacharias FJBenefits and potential harm of lowering high blood pressure. Lancet1987; 1: 581–4.
26.
26. D'Agostino RB, Belanger AJ, Kannel WB, Cruickshank JMRelation of low diastolic blood pressure to coronary heart disease death in presence of myocardial infarction: the Framingham study. Br Med J1991; 303: 385–9.
27.
27. WHO: World Health OrganizationInternational classification of disease. 1955 revision. Geneve: World Health Organization, 1957.
28.
28. WHO: World Health OrganizationInternational classification of diseases, injuries and causes of death. Eighth Revision Oslo Norway: Statistisk Sentralbyrå, 1973 (in Norwegian).
29.
29. WHO: World Health Organization. Arterial hypertension and ischemic heart disease: Preventive aspects. Report of an expert committee. WHO Tech Rep Ser No 231, 1962.
30.
30. McCullagh P, Nelder JAGeneralized linear models. London: Chapman and Hall, 1983.
31.
31. The use of medical drugs in Norway. Norwegian Medical Depot, Oslo1989.
32.
32. Collins R, Peto R, MacMahon Set al: Blood pressure, stroke, and coronary heart disease. Part 2, short-term reductions in blood pressure: overview of randomized drug trials in their epidemiological context. Lancet1990; 335: 827–38.
33.
33. Torvik A, Stenwig JTChanges in frequency of cerebrovascular diseases in Oslo, Norway, 1958–1977. Stroke1981; 12: 816–23.
34.
34. Neaton JD, Wentworth DSerum cholesterol, blood pressure, cigarette smoking and death from coronary heart disease. Arch Intern Med1992; 152: 56–64.
35.
35. Hansson L, Lundin SHypertension and coronary heart disease: cause and consequence or associated diseases?Am J Med1984; 41–4.
36.
36. Prentice RL, Shimizu Y, Lin CHet alSerial blood pressure measurements and cardiovascular disease in a Japanese cohort. Am J Epidemiol1982; 116: 1–28.
37.
37. National Health Screening Service: Prediction based on one or two measurements of a variable. Rep. 3/89, Oslo, Norway 1991.
38.
38. Bjartveit K, Foss OP, Gjervig T, Lund-Larsen PGThe cardiovascular disease study in Norwegian counties. Background and organization. Acta Med Scand1979; Suppl 634: 36.
39.
39. Coope J, Warrender TS, McPherson KThe prognostic significance of blood pressure in the elderly. J Hum Hypertens1988; 2: 79–88.
40.
40. Mattila K, Haavisto M, Rajaja Set alBlood pressure and survival in the very old. Br Med J1988; 296: 887–9.
41.
41. Langer RD, Ganiats TG, Barrett-Connor EParadoxical survival of elderly men with high blood pressure. Br Med J1989; 298: 1356–7.
42.
42. Heikinheimo RJ, Haavisto MV, Kaarela RH, et alBlood pressure in the very old. J Hypertens1990; 8: 361–7.
43.
43. Taylor JO, Cornoni-Hunfley J, Curb JD, et alBlood pressure and mortality risk in the elderly. Am J Epidemiol1991; 134: 489–501.
